Ipca Laboratories Limited has notified the closure of the trading window for dealing in its securities from April 1, 2025, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The closure will continue until 48 hours after the declaration of the company’s audited financial results for the 4th quarter and financial year ending March 31, 2025.

This move is intended to ensure compliance with the Company’s Code of Conduct and prevent any misuse of unpublished price-sensitive information (UPSI) during the sensitive period when financial results are pending.

Details of Trading Window Closure

• The trading window will be closed starting April 1, 2025, and will remain closed until 48 hours after the declaration of audited financial results for the quarter and year ending March 31, 2025.

• During this period, all insiders, including Directors, Promoters, Key Managerial Personnel (KMPs), and other Designated Persons, along with their immediate relatives, are prohibited from trading in the company’s securities.

• The date of the Board meeting for the consideration and approval of the audited financial results will be communicated to the stock exchanges in due course.

Regulatory Compliance and Purpose

The trading window closure is a necessary measure taken by Ipca Laboratories Limited in line with SEBI (Prohibition of Insider Trading) Regulations, 2015. These regulations aim to prevent any insider trading or misuse of price-sensitive information by individuals who have access to unpublished financial data before it becomes public.

Key Guidelines During Trading Window Closure

• Designated Persons and their immediate relatives are strictly prohibited from buying, selling, or dealing in the company’s securities during the closure period.

• Any violation of these provisions may lead to severe regulatory consequences, including penalties and possible legal action by SEBI.

Board Meeting and Financial Results Announcement

The Board Meeting for the approval of the audited financial results for the quarter and year ending March 31, 2025, will be held on a date that will be intimated to the stock exchanges separately. Following the Board’s approval, the trading window will reopen 48 hours after the public announcement of financial results.

Objective of Trading Window Closure

The objective of this measure is to maintain fairness and transparency in the financial markets by ensuring that price-sensitive information is not misused by insiders. This practice aligns with the Company’s Code of Conduct and adheres to regulatory requirements.

Duration and End Date

• The closure period starts on April 1, 2025, and extends until 48 hours after the financial results for the 4th quarter and financial year ended March 31, 2025, are declared.

• The exact date of the Board Meeting and subsequent re-opening of the trading window will be notified in due course.

Commitment to Regulatory Compliance

Ipca Laboratories remains committed to upholding the highest standards of corporate governance and regulatory compliance. The company continuously works towards ensuring that all its operations are carried out with transparency, fairness, and integrity.

In conclusion, Ipca Laboratories Limited’s trading window closure is a proactive step to ensure compliance with SEBI regulations and prevent any potential insider trading violations. All concerned parties are expected to adhere to the guidelines, and any further updates regarding the Board Meeting and financial results declaration will be shared with the stock exchanges in due course.

The Upcoming IPOs in this week and coming weeks are Arisinfra Solutions Limited, Identixweb Limited, Retaggio Industries Limited, Infonative Solutions Limited.

The Current active IPO are ATC Energies System Limited, Shri Ahimsa Naturals Limited, Desco Infratech Limited, Rapid Fleet Management Services, Active Infrastructures Limited.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.